Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.36 | 25.26 |
PEG Ratio (TTM) | -2.36 | 8.10 |
P/S Ratio (TTM) | 0.84 | 0.74 |
P/B Ratio (TTM) | 18.08 | 3.11 |
P/FCF Ratio (TTM) | -11.11 | 52.92 |
Price to 5YR AVG Earnings Ratio | N/A | 20.91 |
Price to 5YR AVG FCF Ratio | N/A | 15.77 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -20.82% | 4.14% |
ROE (TTM) | -109.60% | 13.00% |
Net Profit Margin (TTM) | -5.84% | 2.93% |
ROIC 5YR AVG | N/A | 25.58% |
Growth (23%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 2.18% | -141.01% | N/A |
Revenue | 11.75% | 23.76% | N/A |
Net Income | 1.28% | -126.86% | N/A |
Cash Flow | -660.86% | -372.48% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.60 | 1.10 |
Quick Ratio (TTM) | 1.60 | 1.07 |
D/E Ratio (TTM) | 1.85 | 0.74 |
Interest Coverage (TTM) | -5.14 | 7.37 |
Piotroski F-Score | 2 | 7 |
Altman Z-Score | 3.54 | 3.13 |
LTL to 5YR AVG FCF | N/A | 3.39 |
Shares Outstanding Growth 5YR AVG | N/A | 0.69% |